Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3ELM

Crystal Structure of MMP-13 Complexed with Inhibitor 24f

3ELM の概要
エントリーDOI10.2210/pdb3elm/pdb
分子名称Collagenase 3, ZINC ION, CALCIUM ION, ... (5 entities in total)
機能のキーワードmetallo-enzyme, mmp-13, carboxylate inhibitor, calcium, collagen degradation, disease mutation, extracellular matrix, glycoprotein, hydrolase, metal-binding, metalloprotease, polymorphism, protease, secreted, zinc, zymogen
由来する生物種Homo sapiens (Human)
細胞内の位置Secreted, extracellular space, extracellular matrix : P45452
タンパク質・核酸の鎖数2
化学式量合計40034.20
構造登録者
Kulathila, R.,Monovich, L.,Koehn, J. (登録日: 2008-09-22, 公開日: 2009-07-21, 最終更新日: 2024-02-21)
主引用文献Monovich, L.G.,Tommasi, R.A.,Fujimoto, R.A.,Blancuzzi, V.,Clark, K.,Cornell, W.D.,Doti, R.,Doughty, J.,Fang, J.,Farley, D.,Fitt, J.,Ganu, V.,Goldberg, R.,Goldstein, R.,Lavoie, S.,Kulathila, R.,Macchia, W.,Parker, D.T.,Melton, R.,O'Byrne, E.,Pastor, G.,Pellas, T.,Quadros, E.,Reel, N.,Roland, D.M.,Sakane, Y.,Singh, H.,Skiles, J.,Somers, J.,Toscano, K.,Wigg, A.,Zhou, S.,Zhu, L.,Shieh, W.C.,Xue, S.,McQuire, L.W.
Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13
J.Med.Chem., 52:3523-3538, 2009
Cited by
PubMed Abstract: The matrix metalloproteinase enzyme MMP-13 plays a key role in the degradation of type II collagen in cartilage and bone in osteoarthritis (OA). An effective MMP-13 inhibitor would therefore be a novel disease modifying therapy for the treatment of arthritis. Our efforts have resulted in the discovery of a series of carboxylic acid inhibitors of MMP-13 that do not significantly inhibit the related MMP-1 (collagenase-1) or tumor necrosis factor-alpha (TNF-alpha) converting enzyme (TACE). It has previously been suggested (but not proven) that inhibition of the latter two enzymes could lead to side effects. A promising carboxylic acid lead 9 was identified and a convergent synthesis developed. This paper describes the optimization of 9 and the identification of a compound 24f for further development. Compound 24f is a subnanomolar inhibitor of MMP-13 (IC(50) value 0.5 nM and K(i) of 0.19 nM) having no activity against MMP-1 or TACE (IC(50) of >10000 nM). Furthermore, in a rat model of MMP-13-induced cartilage degradation, 24f significantly reduced proteoglycan release following oral dosing at 30 mg/kg (75% inhibition, p < 0.05) and at 10 mg/kg (40% inhibition, p < 0.05).
PubMed: 19422229
DOI: 10.1021/jm801394m
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 3elm
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon